Timothy Kutzkey

Timothy W.
Kutzkey was the founder of Nurix Therapeutics, Inc., founded in 2009, where the title held was Chairman from 2016 to 2019.
Dr. Kutzkey is the founder of Kimia Therapeutics, Inc., founded in 2023, where the title held is Director since 2023.
Dr. Kutzkey is also the founder of Nura Bio, Inc...
Dr. Kutzkey is currently Chief Executive Officer at Reina Bio, Inc. Dr. Kutzkey is currently Chairman at Neurona Therapeutics, Inc. Dr. Kutzkey is currently Chairman at Carmot Therapeutics, Inc. since 2010.
Dr. Kutzkey is currently Director at Kallyope, Inc. Dr. Kutzkey is currently Director at Plexium, Inc. Dr. Kutzkey is currently Director at Synthekine, Inc. Dr. Kutzkey is currently Director at Cajal Therapeutics.
Dr. Kutzkey is currently Director at InduPro, Inc. Dr. Kutzkey is currently Director at Surrozen, Inc. since 2025.
Dr. Kutzkey is currently Managing Partner at The Column Group LLC since 2007.
Dr. Kutzkey is currently Managing Partner at TCG Labs-Soleil.
Former positions include President, Chief Executive Officer & Director at Peloton Therapeutics, Inc. Former positions include Chief Executive Officer & Director at Surrozen Operating, Inc. Former position as Director at Cyterix Pharmaceuticals, Inc. Former position as Independent Director at Surrozen, Inc. from 2016 to 2024.
Former position as Principal at KAI Pharmaceuticals, Inc. from 2006 to 2007.
Education includes an undergraduate degree from Stanford University conferred in 1997 and a doctorate from the University of California, Berkeley conferred in 2005.